Clinical Trial Update: A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).

View source ↗

Summary

Pfizer-sponsored retrospective study validating chart-based clinical diagnosis of wild-type transthyretin amyloid cardiomyopathy and non-amyloid heart failure a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Wild-type Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Pfizer | Conditions: ATTR-CM | Status: COMPLETED | Results posted: 2025-01-03